nicotine has been researched along with Cognitive Decline in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (62.07) | 24.3611 |
| 2020's | 11 (37.93) | 2.80 |
| Authors | Studies |
|---|---|
| Alhowail, AH | 1 |
| Cheng, HQ; Geng, PP; Hu, XY; Jin, XC; Shu, H; Sun, YY; Wang, H; Wang, MW; Wang, Q; Wang, W; Wang, XN; Zhang, JF | 1 |
| Gao, EW; Hou, J; Huang, C; Huang, J; Huang, YD; Lai, SY; Li, T; Liu, JJ; Liu, W; Lu, SY; Nie, LL; Wang, L; Wu, DS; Yang, XF; Ye, F; Yuan, CJ; Yuan, J; Zhang, JF; Zhou, L; Zhu, B; Zhu, FQ; Zhu, QQ | 1 |
| Chen, MF; Chen, PY; Lee, TJF; Shih, CC | 1 |
| Burt, B; Li, J | 1 |
| Farokhi, N; Motaghinejad, M; Motevalian, M; Safari, S | 1 |
| Andreasen, JT; Aznar, S; Ipsen, TH; Kohlmeier, KA; Polli, FS; Scharff, MB | 1 |
| Jin, X; Shen, X; Shu, H; Song, M; Sun, Y; Wang, M; Zhang, J | 1 |
| Concheiro-Guisan, M; Hahn, B; Harvey, AN; Huestis, MA; Ross, TJ; Stein, EA | 1 |
| Heldt, NA; McGary, HM; Persidsky, Y; Reichenbach, N | 1 |
| Albert, KM; Mayer, IA; Newhouse, PA; Taylor, WD; Vega, JN | 2 |
| Bredt, DS; Davini, WB; Gu, S; Harrington, AW; Lord, B; Matta, JA; Siuda, ER | 1 |
| Brennan, KA; Ellenbroek, BA; Waterhouse, U | 1 |
| Curran, HV; Freeman, TP; Hindocha, C; Shaban, NDC; Xia, JX | 1 |
| Kamari, F; Majdi, A; Sadigh-Eteghad, S; Vafaee, MS | 1 |
| Ji, F; Li, D; Li, J; Liu, H; Tang, W; Wan, T; Wei, P; Zheng, Q; Zhou, H; Zhou, J | 1 |
| Li, C; Li, R; Zhou, C; Zhou, Y | 1 |
| Bryant, J; Can, A; Davis, H; Gould, TD; Guo, M; Huse, J; Jackson, M; Royal, W | 1 |
| Cather, C; Dodds, EB; Evins, AE; Fava, M; Hanly, A; Hudziak, V; Mischoulon, D; Nadal, M; Pachas, GN; Schoenfeld, DA; Schuster, RM; Sobolewski, S; Stoeckel, L; Ulysse, C; Zhang, H | 1 |
| Gould, TJ; Mooney-Leber, SM | 1 |
| Albert, K; Antal, A; Boyd, BD; Conley, AC; Gandelman, JA; Kang, H; Newhouse, P; Taylor, WD | 1 |
| Berrendero, F; Grande, MT; Maldonado, R; Saravia, R; Ten-Blanco, M | 1 |
| Kaakkola, S; Tuominen, R | 1 |
| Cooper, C; Li, R; Livingston, G; Lyketsos, C | 1 |
| Buratovic, S; Eriksson, P; Fredriksson, A; Stenerlöw, B; Sundell-Bergman, S | 1 |
| Asanuma, M; Kanemoto, E; Kanzaki, H; Kitamura, Y; Machida, A; Miyazaki, I; Naito, N; Nakamura, Y; Sendo, T; Sugimoto, M | 1 |
| Aisen, P; Coderre, E; Howard, D; Kellar, K; Levin, ED; Newhouse, P; Pfaff, A; Wesnes, K; White, H; Wilkins, H | 1 |
| Gold, M; Howard, D; Kryscio, RJ; Newhouse, PA | 1 |
7 review(s) available for nicotine and Cognitive Decline
| Article | Year |
|---|---|
Mechanisms underlying cognitive impairment induced by prenatal nicotine exposure: a literature review.
Topics: Animals; Cognition; Cognitive Dysfunction; Female; Fetal Development; Hippocampus; Humans; Nicotine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Nicotinic | 2021 |
The electronic cigarette epidemic in youth and young adults: A practical review.
Topics: Adolescent; Adult; Age Factors; Cognitive Behavioral Therapy; Cognitive Dysfunction; Electronic Nicotine Delivery Systems; Female; Humans; Male; Mood Disorders; Nicotine; Prevalence; Tobacco Use Cessation Devices; Tobacco Use Disorder; Vaping; Young Adult | 2020 |
Effects of Electronic Nicotine Delivery Systems and Cigarettes on Systemic Circulation and Blood-Brain Barrier: Implications for Cognitive Decline.
Topics: Animals; Blood-Brain Barrier; Cerebrovascular Circulation; Cognitive Dysfunction; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Tobacco Products; Vaping | 2021 |
Revisiting nicotine's role in the ageing brain and cognitive impairment.
Topics: Animals; Brain; Cognitive Dysfunction; Dementia; Humans; Nicotine | 2017 |
The long-term cognitive consequences of adolescent exposure to recreational drugs of abuse.
Topics: Adolescent; Adolescent Behavior; Adolescent Development; Animals; Brain; Cannabis; Cognitive Dysfunction; Ethanol; Humans; Nicotine; Substance-Related Disorders | 2018 |
[Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties].
Topics: Alzheimer Disease; Ataxia; Benzazepines; Cognitive Dysfunction; Epilepsy, Frontal Lobe; Humans; Mutation; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinoxalines; Receptors, Nicotinic; Tobacco Use Cessation Devices; Varenicline | 2013 |
Treatment for mild cognitive impairment: systematic review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Cognitive Dysfunction; Dopamine Agonists; Drugs, Chinese Herbal; Exercise Therapy; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Nicotine; Nicotinic Agonists; Phytotherapy; Piribedil; Psychotherapy, Group; Quality of Life; Randomized Controlled Trials as Topic; Therapy, Computer-Assisted; Treatment Outcome; Vitamins | 2013 |
6 trial(s) available for nicotine and Cognitive Decline
| Article | Year |
|---|---|
Subjective cognition and mood in persistent chemotherapy-related cognitive impairment.
Topics: Chemotherapy-Related Cognitive Impairment; Cognition; Cognitive Dysfunction; Female; Humans; Nicotine; Quality of Life | 2022 |
Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial.
Topics: Adult; Attention; Blood Pressure; Cannabinoids; Cigarette Smoking; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Marijuana Smoking; Memory, Short-Term; Mental Recall; Nicotine; Young Adult | 2017 |
Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Cognitive Dysfunction; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Cessation Devices | 2018 |
Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.
Topics: Administration, Cutaneous; Affect; Aged; Cognitive Dysfunction; Depressive Disorder, Major; Female; Humans; Late Onset Disorders; Male; Middle Aged; Nicotine; Nicotinic Agonists; Non-Smokers | 2018 |
Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cancer Survivors; Cognition; Cognitive Dysfunction; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Pilot Projects; Quality of Life; Self Report; Survivors; Transdermal Patch | 2019 |
Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Attention; Body Weight; Cognitive Dysfunction; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mental Recall; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Reaction Time; Vital Signs | 2012 |
16 other study(ies) available for nicotine and Cognitive Decline
| Article | Year |
|---|---|
Nicotine pretreatment alleviates MK-801-induced behavioral and cognitive deficits in mice by regulating Pdlim5/CRTC1 in the PFC.
Topics: Animals; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Mice; Nicotine; Prefrontal Cortex; Transcription Factors | 2023 |
Effect modification by aging on the associations of nicotine exposure with cognitive impairment among Chinese elderly.
Topics: Aged; Aging; Cognitive Dysfunction; DNA, Mitochondrial; East Asian People; Humans; Nicotine | 2023 |
Differential blockade by huperzine A and donepezil of sympathetic nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilations in porcine basilar arteries.
Topics: Alkaloids; Alzheimer Disease; Animals; Basilar Artery; Brain Stem; Calcium; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Dose-Response Relationship, Drug; Humans; Models, Animal; Nicotine; Nitrergic Neurons; Oocytes; Patch-Clamp Techniques; Rats; Receptors, Nicotinic; Sesquiterpenes; Swine; Synaptic Transmission; Vasodilation; Xenopus laevis | 2020 |
Molecular, histological and behavioral evidences for neuroprotective effects of minocycline against nicotine-induced neurodegeneration and cognition impairment: Possible role of CREB-BDNF signaling pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hippocampus; Lipid Peroxidation; Male; Minocycline; Neurodegenerative Diseases; Neuroprotection; Neuroprotective Agents; Nicotine; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Superoxide Dismutase | 2020 |
Prenatal nicotine exposure in mice induces sex-dependent anxiety-like behavior, cognitive deficits, hyperactivity, and changes in the expression of glutamate receptor associated-genes in the prefrontal cortex.
Topics: Animals; Anxiety; Behavior, Animal; Cognition; Cognitive Dysfunction; Female; Gene Expression; Hyperkinesis; Locomotion; Male; Maze Learning; Memory, Short-Term; Mice; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Glutamate; Sex Factors | 2020 |
Acute Nicotine Treatment Alleviates LPS-Induced Impairment of Fear Memory Reconsolidation Through AMPK Activation and CRTC1 Upregulation in Hippocampus.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Cognitive Dysfunction; Fear; Hippocampus; Inflammation; Lipopolysaccharides; Male; Memory Consolidation; Mental Recall; Nicotine; Nicotinic Agonists; Protein Kinases; Rats; Rats, Sprague-Dawley; Transcription Factors; Up-Regulation | 2020 |
Nicotinic receptor modulation of the default mode network.
Topics: Adult; Brain; Cognition; Cognitive Dysfunction; Default Mode Network; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Mecamylamine; Middle Aged; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prefrontal Cortex; Reaction Time; Receptors, Nicotinic; Task Performance and Analysis | 2021 |
NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain.
Topics: Animals; Binding Sites; Brain; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Cell Line; Cognitive Dysfunction; Conotoxins; Humans; Iodine Radioisotopes; Membrane Proteins; Mice; Mice, Knockout; Molecular Chaperones; Neurons; Nicotine; Protein Binding; Protein Subunits; Pyridines; Radiopharmaceuticals; Receptors, Nicotinic | 2017 |
Nicotine self-administration reverses cognitive deficits in a rat model for schizophrenia.
Topics: Animals; Cognition; Cognitive Dysfunction; Disease Models, Animal; Female; Lipopolysaccharides; Male; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Self Administration | 2018 |
Nicotine-Induced Neuroprotection against Cognitive Dysfunction after Partial Hepatectomy Involves Activation of BDNF/TrkB Signaling Pathway and Inhibition of NF-κB Signaling Pathway in Aged Rats.
Topics: Aging; Animals; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Hepatectomy; Hippocampus; Male; Neuroprotection; NF-kappa B; Nicotine; Rats; Rats, Sprague-Dawley; Receptor, trkB; Signal Transduction | 2018 |
Exercise improves nicotine reward-associated cognitive behaviors and related α7 nAChR-mediated signal transduction in adolescent rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Cigarette Smoking; Cognition; Cognitive Dysfunction; Ganglionic Stimulants; Hippocampus; Male; Maze Learning; Nicotine; Physical Conditioning, Animal; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reward; Signal Transduction | 2018 |
Cigarette smoke and nicotine effects on brain proinflammatory responses and behavioral and motor function in HIV-1 transgenic rats.
Topics: AIDS Dementia Complex; Animals; Cigarette Smoking; Cognitive Dysfunction; Disease Models, Animal; Disease Progression; Female; Frontal Lobe; Gene Expression Regulation; HIV-1; Humans; Interleukin-1; Interleukin-6; Locomotion; Male; Nicotine; Psychomotor Performance; Rats; Rats, Inbred F344; Rats, Transgenic; Rotarod Performance Test; Tumor Necrosis Factor-alpha | 2018 |
Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice.
Topics: Animals; Anti-Inflammatory Agents; Attention; Brain; Cannabidiol; Cognition; Cognition Disorders; Cognitive Dysfunction; Hippocampus; Male; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Microglia; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Smoking; Smoking Cessation; Tobacco Use Disorder | 2019 |
Developmental effects of fractionated low-dose exposure to gamma radiation on behaviour and susceptibility of the cholinergic system in mice.
Topics: Animals; Animals, Newborn; Behavioral Symptoms; Brain; Cholinergic Neurons; Cognitive Dysfunction; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Gamma Rays; Male; Mice; Nicotine; Radiation Tolerance | 2016 |
Influence of nicotine on doxorubicin and cyclophosphamide combination treatment-induced spatial cognitive impairment and anxiety-like behavior in rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antineoplastic Agents; Anxiety; Behavior, Animal; Cell Proliferation; Cognitive Dysfunction; Cyclophosphamide; Diazepam; Doxorubicin; Drug Interactions; Hippocampus; Male; Nicotine; Nicotinic Antagonists; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Spatial Memory | 2017 |
Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial.
Topics: Clinical Trials as Topic; Cognitive Dysfunction; Data Interpretation, Statistical; Double-Blind Method; Humans; Nicotine; Pilot Projects; Transdermal Patch; Treatment Outcome | 2012 |